Difficulty: Medium
Average Score: 64%
Practice
Indicate D2 receptor agonist with antiparkinsonian activity:
Correct answer
C
Rationale
In this question, the correct answer is C) Bromocriptine. Bromocriptine is a D2 receptor agonist with antiparkinsonian activity. Dopamine agonists like bromocriptine work by directly stimulating dopamine receptors, which helps alleviate symptoms of Parkinson's disease.
Option A) Sinemet is a combination of carbidopa and levodopa, which is a precursor to dopamine and not a D2 receptor agonist.
Option B) Levodopa, as mentioned above, is a precursor to dopamine and is converted to dopamine in the brain to help manage Parkinson's symptoms, but it is not a D2 receptor agonist.
Option D) Selegiline is a monoamine oxidase type B (MAO-B) inhibitor used in the treatment of Parkinson's disease, but it is not a D2 receptor agonist.
Educationally, understanding the mechanisms of action of different medications used in Parkinson's disease is crucial for healthcare professionals to effectively manage patients with this condition. Knowing that bromocriptine is a D2 receptor agonist helps in selecting appropriate treatment options based on the underlying pathophysiology of the disease. This knowledge is essential for nurses, pharmacists, and other healthcare providers involved in the care of patients with Parkinson's disease.
Option A) Sinemet is a combination of carbidopa and levodopa, which is a precursor to dopamine and not a D2 receptor agonist.
Option B) Levodopa, as mentioned above, is a precursor to dopamine and is converted to dopamine in the brain to help manage Parkinson's symptoms, but it is not a D2 receptor agonist.
Option D) Selegiline is a monoamine oxidase type B (MAO-B) inhibitor used in the treatment of Parkinson's disease, but it is not a D2 receptor agonist.
Educationally, understanding the mechanisms of action of different medications used in Parkinson's disease is crucial for healthcare professionals to effectively manage patients with this condition. Knowing that bromocriptine is a D2 receptor agonist helps in selecting appropriate treatment options based on the underlying pathophysiology of the disease. This knowledge is essential for nurses, pharmacists, and other healthcare providers involved in the care of patients with Parkinson's disease.